MAP4 REGULATION OF CARDIAC MICROTUBULE NETWORK DENSITY

MAP4 心脏微管网络密度的调节

基本信息

  • 批准号:
    7885169
  • 负责人:
  • 金额:
    $ 36.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-15 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have shown at the levels of isolated cell, isolated tissue and the intact heart in vivo that increased microtubule network density is one cause of contractile dysfunction in high wall stress right or left ventricular hypertrophy. We then showed that increased affinity of microtubule-associated protein 4 [MAP4] for microtubules is the primary determinant of hypertrophy-related microtubule network sta- bilization and densification, and is thereby responsible for both the contractile dysfunction and associ- ated defects in microtubule-based intracellular trafficking that we have also described in this setting. MAP4 phosphorylation status appears to determine MAP4 affinity for microtubules. Therefore, this application intends to characterize the persistent changes in site-specific MAP4 phosphorylation status in an animal model of pathological pressure overload hypertrophy, with a parallel model of physiologi- cal volume overload hypertrophy serving as a control for any effects of growth per se. We will then delineate the regulation of MAP4 phosphorylation by examining relevant kinases and phosphatases. We believe that the successful execution of the proposed research will likely generate important new information to help understand the cellular and molecular mechanisms underlying cardiac hypertro- phy and failure. In addition, while our own end point of interest is the microtubule, the persistent increase in cardiac phosphatase activity and its regulation as shown in our preliminary data is almost certainly of more general importance to established hypertrophy- and failure-related disease mecha- nisms, many of which involve phosphorylation-dependent alterations of structural and regulatory pro- teins of the sarcoplasmic reticulum, the myofibril, and the extra-myofilament cytoskeleton. Thus, this work may serve as an example to help conceptualize the likely mechanistic convergence of a number of heretofore apparently disparate abnormalities of the hypertrophied and failing heart. PUBLIC HEALTH RELEVANCE: Congestive heart failure is the leading cause of hospital admission and readmission in Americans aged 65 or greater. The contractile dysfunction that characterizes systolic heart failure is a maladaptive myo- cardial response to several pathological challenges, including sustained cardiac pressure overloading. This study will identify the mechanism underlying one important cause for this dysfunction in the failing heart: alterations in the microtubule network of the cardiac muscle cell cytoskeleton.
描述(由申请人提供): 我们已经在离体细胞、离体组织和完整心脏的水平上表明,微管网络密度增加是高室壁应力右室或左室肥厚收缩功能障碍的原因之一。然后,我们发现微管相关蛋白4 [MAP4]对微管的亲和力增加是肥大相关微管网络稳定和致密化的主要决定因素,从而导致收缩功能障碍和基于微管的细胞内运输的相关缺陷,我们也在此背景下进行了描述。MAP4磷酸化状态似乎决定了MAP4对微管的亲和力。因此,本申请旨在表征病理性压力超负荷肥大动物模型中位点特异性MAP 4磷酸化状态的持续变化,同时将生理性容量超负荷肥大的平行模型用作生长本身任何影响的对照。然后,我们将描绘的MAP 4磷酸化的调节,通过检查相关的激酶和磷酸酶。我们相信,拟议研究的成功执行可能会产生重要的新信息,以帮助理解心脏肥厚和衰竭的细胞和分子机制。此外,虽然我们自己感兴趣的终点是微管,但我们的初步数据显示,心脏磷酸酶活性及其调节的持续增加几乎肯定对已建立的肥大和衰竭相关疾病机制具有更普遍的重要性,其中许多涉及肌浆网、肌原纤维、和肌丝外细胞骨架。因此,这项工作可以作为一个例子,以帮助概念化可能的机械收敛的一些迄今为止明显不同的异常肥厚和衰竭的心脏。 公共卫生相关性: 充血性心力衰竭是65岁或以上美国人入院和再入院的主要原因。收缩功能障碍是收缩性心力衰竭的特征,是对几种病理挑战(包括持续的心脏压力超负荷)的适应不良的心肌反应。这项研究将确定在衰竭的心脏中这种功能障碍的一个重要原因的机制:心肌细胞细胞骨架微管网络的改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE COOPER其他文献

GEORGE COOPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE COOPER', 18)}}的其他基金

Beta-Adrenergic Control of the Pathological Cardiac Microtubule Network
病理性心脏微管网络的β-肾上腺素能控制
  • 批准号:
    8111961
  • 财政年份:
    2010
  • 资助金额:
    $ 36.88万
  • 项目类别:
MAP4 REGULATION OF CARDIAC MICROTUBULE NETWORK DENSITY
MAP4 心脏微管网络密度的调节
  • 批准号:
    8063058
  • 财政年份:
    2010
  • 资助金额:
    $ 36.88万
  • 项目类别:
Beta-Adrenergic Control of the Pathological Cardiac Microtubule Network
病理性心脏微管网络的β-肾上腺素能控制
  • 批准号:
    7952783
  • 财政年份:
    2010
  • 资助金额:
    $ 36.88万
  • 项目类别:
Connexin Distribution in Physiological Versus Pathological Cardiac Hypertrophy
生理性与病理性心脏肥大中的连接蛋白分布
  • 批准号:
    8195558
  • 财政年份:
    2009
  • 资助金额:
    $ 36.88万
  • 项目类别:
Connexin Distribution in Physiological Versus Pathological Cardiac Hypertrophy
生理性与病理性心脏肥大中的连接蛋白分布
  • 批准号:
    7903963
  • 财政年份:
    2009
  • 资助金额:
    $ 36.88万
  • 项目类别:
Connexin Distribution in Physiological Versus Pathological Cardiac Hypertrophy
生理性与病理性心脏肥大中的连接蛋白分布
  • 批准号:
    7788252
  • 财政年份:
    2009
  • 资助金额:
    $ 36.88万
  • 项目类别:
CYTOSKELETON AND CONTRACTILE DYSFUNCTION IN HYPERTROPHY
肥大症中的细胞骨架和收缩功能障碍
  • 批准号:
    6808267
  • 财政年份:
    2003
  • 资助金额:
    $ 36.88万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    6808272
  • 财政年份:
    2003
  • 资助金额:
    $ 36.88万
  • 项目类别:
CORE--CELL ISOLATION AND CULTURE
核心——细胞分离与培养
  • 批准号:
    6808274
  • 财政年份:
    2003
  • 资助金额:
    $ 36.88万
  • 项目类别:
CYTOSKELETON AND CONTRACTILE DYSFUNCTION IN HYPERTROPHY
肥大症中的细胞骨架和收缩功能障碍
  • 批准号:
    6631281
  • 财政年份:
    2002
  • 资助金额:
    $ 36.88万
  • 项目类别:

相似海外基金

Elucidation of chromatin structure produced by CENP-B acidic region and application to new synthetic transcription factors.
CENP-B酸性区产生的染色质结构的阐明及其在新合成转录因子中的应用。
  • 批准号:
    22K14866
  • 财政年份:
    2022
  • 资助金额:
    $ 36.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了